Workflow
RINGPU(300119)
icon
Search documents
瑞普生物(300119) - 关于2022年限制性股票激励计划部分限制性股票回购注销完成工商变更登记的公告
2025-07-11 10:36
证券代码:300119 证券简称:瑞普生物 公告编号:2025-053 瑞普生物股份有限公司 关于 2022 年限制性股票激励计划部分限制性股票 回购注销完成工商变更登记的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误 导性陈述或重大遗漏。 法定代表人:李守军 注册资本:肆亿陆仟肆佰柒拾伍万肆仟柒佰零陆元人民币 成立日期:2001 年 8 月 2 日 经营范围:一般项目:技术服务、技术开发、技术咨询、技术交流、技术转 让、技术推广;饲料原料销售;饲料添加剂销售;消毒剂销售(不含危险化学品); 宠物食品及用品批发;宠物食品及用品零售;专用化学产品销售(不含危险化学 1 瑞普生物股份有限公司(简称"公司")于 2025 年 4 月 24 日召开 2024 年 年度股东大会,审议通过了《关于回购注销 2022 年限制性股票激励计划部分限 制性股票的议案》和《关于修改公司章程的议案》,同意回购注销公司 2022 年 限制性股票激励计划部分限制性股票 1,093,200 股,并相应减少公司注册资本。 注销完成后,公司总股本由 465,847,906 股减至 464,754,706 股, ...
瑞普生物(300119) - 关于持股5%以上股东梁武持股拟在一致行动人之间内部转让的公告
2025-07-11 10:36
瑞普生物股份有限公司 关于持股 5%以上股东梁武持股拟在一致行动人之间内部转让 证券代码:300119 证券简称:瑞普生物 公告编号:2025-052 的公告 股东梁武、上海阿杏投资管理有限公司-阿杏延安9号私募证券投资基金、图灵私募基 金管理(海南)有限公司-图灵麦田6号私募证券投资基金保证向本公司提供的信息内容真 实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示: 1、瑞普生物股份有限公司(以下简称"公司""本公司")于近日收到持 股 5%以上股东梁武先生(本人持股 23,716,898 股,占本公司总股本比例 5.10%) 的告知函,因家庭资产规划需要,计划在未来三个月内以大宗交易方式向其一致 行动人转让本公司股份 90.00 万股,占本公司总股本比例 0.19%。 2、本次股份变动属于公司持股 5%以上股东梁武及其一致行动人之间股份 的内部转让,其合计持股数量和比例未发生变化,不会导致公司控制权发生变化, 不会影响公司治理结构和持续经营。 一、股东梁武的基本情况 1、股东名称:梁武 2、持股情况:梁武本人持有本公司股份 ...
农林牧渔行业2025年中报前瞻:养殖盈利兑现,“后周期”景气上行,宠物食品龙头延续较快增长
Investment Rating - The report rates the agricultural, forestry, animal husbandry, and fishery industry as "Overweight" due to expected overall profit improvement in the sector [3][4]. Core Insights - The report highlights that the profitability of pig farming is expected to improve, with a stable pig price and a significant increase in average profit per head for self-bred pigs [4]. - Poultry farming shows a mixed outlook, with white chicken prices bottoming out and yellow chicken profitability declining, while egg-laying chicks continue to experience high demand [4]. - The pet food sector is projected to maintain high growth, with leading companies showing strong online sales growth, despite a decline in exports to the U.S. due to tariffs [4]. - Animal health is recovering, with increased demand for vaccines and improved sales of veterinary preparations [4]. - The seed industry faces challenges with declining corn prices and increased competition, leading to pressure on the performance of leading seed companies [4]. Summary by Sections Pig Farming - The average price of pigs in H1 2025 is expected to be 14.80 CNY/kg, a decrease of 4.2% year-on-year, while the average profit for self-bred pigs is projected at 69.04 CNY/head, recovering from a loss of 24.82 CNY/head in H1 2024 [4]. Poultry Farming - White chicken prices are under pressure due to oversupply, with the average price for commodity broiler chicks at 2.4 CNY/bird, down 21% year-on-year. Yellow chicken prices are also declining, with the average price for Qingjiao chicken at 8.9 CNY/kg, down 19% year-on-year [4]. Pet Food - The domestic pet food market is experiencing a growth rate of 17% in online GMV for the first five months of 2025, compared to 14% in the same period of 2024. Leading companies like Guibao Pet and Zhongchong Co. show growth rates of 51% and 26%, respectively [4]. Animal Health - The demand for veterinary vaccines has increased, with a 15.8% year-on-year rise in vaccine approvals in the first five months of 2025. Prices for veterinary preparations like Tylosin and Tiamulin have increased by 39.8% and 9.3%, respectively [4]. Seed Industry - The corn seed market is under pressure due to falling corn prices and high competition, leading to a decline in seed prices and performance expectations for leading seed companies [4].
瑞普生物(300119) - 关于2022年限制性股票激励计划部分限制性股票回购注销完成暨股份变动的公告
2025-07-01 09:02
证券代码:300119 证券简称:瑞普生物 公告编号:2025-051 瑞普生物股份有限公司 关于 2022 年限制性股票激励计划部分限制性股票 回购注销完成暨股份变动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误 导性陈述或重大遗漏。 特别提示: 1、本次回购注销 2022 年限制性股票激励计划已授予但尚未解除限售的限制 性股票数量合计 1,093,200 股,占回购注销前公司总股本的 0.2347%,涉及激励 对象 176 人。 2、经中国证券登记结算有限责任公司深圳分公司审核确认,公司本次部分 限制性股票注销事宜已于 2025 年 6 月 30 日办理完成。 3、注销完成后,公司股份总数由 465,847,906 股减少至 464,754,706 股。 瑞普生物股份有限公司(简称"公司")于 2025 年 4 月 1 日召开的第五届 董事会第二十二次会议、第五届监事会第十八次会议和 2025 年 4 月 24 日召开的 2024 年年度股东大会审议通过了《关于回购注销 2022 年限制性股票激励计划部 分限制性股票的议案》和《关于修改公司章程的议案》,同意回购注销公司 ...
农林牧渔行业周报:宠物保持高景气度,生猪板块布局底部-20250630
Guohai Securities· 2025-06-30 13:32
Investment Rating - The report maintains a "Recommended" rating for the agriculture, forestry, animal husbandry, and fishery industry [1][61]. Core Views - The report highlights that the pig price may experience a turning point due to seasonal factors and policy changes, suggesting a bottoming out phase for the sector [2][12]. - The poultry sector is seeing price declines, but there are signs of marginal improvements in the cycle [3][24]. - The animal health sector is expected to see performance recovery, and there are investment opportunities in the pet medical industry [4][35]. - The planting sector is witnessing a week-on-week rebound in grain prices [5][43]. - The feed sector is experiencing price fluctuations, with a general downward trend [6][46]. - The pet economy is thriving, with domestic brands gaining strength [7][51]. Summary by Sections Pig Industry - The average pig price is currently fluctuating between 14-15 CNY/kg, with a notable increase in average weights compared to previous years [11][12]. - The report recommends focusing on companies with low costs and strong financial health, such as Wens Foodstuffs, Muyuan Foods, and Juxing Agriculture [12][61]. Poultry Industry - The poultry prices are declining, with the white feather chicken price at 3.48 CNY/jin, showing a slight decrease [24][25]. - The report recommends companies like San Nong Development and Yisheng Livestock, while suggesting to pay attention to He Feng and Minhe Livestock [25][61]. Animal Health - The animal health sector is expected to recover, supported by the profitability of the pig farming industry [35][36]. - The pet medical market is projected to grow, with a market size of approximately 840 billion CNY, representing 28% of the pet industry [4][35]. Planting Sector - Grain prices are showing a week-on-week increase, with corn priced at 2353 CNY/ton and wheat at 2446 CNY/ton [43][44]. - The report suggests focusing on companies involved in genetically modified seeds, such as Suqian Agricultural Development and Longping High-tech [43][61]. Feed Sector - Feed prices are experiencing a downward trend, with pig feed at 3.36 CNY/kg [46][47]. - The report recommends Hai Da Group and suggests paying attention to He Feng [47][61]. Pet Industry - The pet market is expected to reach a scale of 300.2 billion CNY in 2024, with a growth rate of 7.5% [51][52]. - The report recommends companies in the pet food sector like Guobao Pet and Zhongchong Co., and in the pet medical sector, it recommends Ruipu Biological [55][61].
瑞普生物(300119) - 2025年第三次临时股东大会决议公告
2025-06-30 10:54
1、本次股东大会无变更、否决议案的情况; 2、本次股东大会以现场投票、网络投票相结合的方式召开。 一、会议召开和出席情况 证券代码:300119 证券简称:瑞普生物 公告编号:2025-050 瑞普生物股份有限公司 2025 年第三次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误 导性陈述或重大遗漏。 特别提示: 瑞普生物股份有限公司(以下简称"公司")2025年6月14日以董事会公告方式 向全体股东发出召开2025年第三次临时股东大会的通知。(公告编号:2025-048)。 本次股东大会采取现场投票、网络投票相结合的方式召开。其中现场会议于2025 年6月30日下午14:30在公司会议室召开,会议由董事长李守军先生主持;通过深圳证 券交易所系统进行网络投票的时间为2025年6月30日09:15-09:25,09:30-11:30,13:00- 15:00;通过深圳证券交易所互联网系统投票的具体时间为2025年6月30日09:15- 15:00期间的任意时间。 公司总股本465,847,906股,扣除公司股份回购专户的股份数后,公司有表决权 股份总数为455, ...
瑞普生物(300119) - 北京市通商律师事务所关于瑞普生物股份有限公司2025年第三次临时股东大会的法律意见书
2025-06-30 10:54
北京市通商律师事务所 关于瑞普生物股份有限公司 2025 年第三次临时股东大会的法律意见书 致:瑞普生物股份有限公司 受瑞普生物股份有限公司(以下简称"公司")聘请,北京市通商律师事务所 指派律师(以下简称"本所律师")出席了公司 2025 年第三次临时股东大会(以下 简称"本次股东大会"),并依据《中华人民共和国公司法》(以下简称"《公司 法》")、《上市公司股东会规则》、《深圳证券交易所上市公司股东会网络投票 实施细则》等法律、法规、规章、规范性文件及《瑞普生物股份有限公司章程》 (以下简称"《公司章程》")的规定,对公司本次股东大会召集及召开程序、出 席会议的人员资格、召集人资格、提案审议情况、股东大会的表决方式、表决程 序和表决结果等重要事项的合法性进行了审核和见证,现出具本法律意见书如下: 一、 本次股东大会的召集与召开程序 本次股东大会由公司第五届董事会第二十四次(临时)会议决议召集。公司 于 2025 年 6 月 14 日在巨潮资讯网(www.cninfo.com.cn)上公告了《关于召开 2025 年第三次临时股东大会的通知》(以下简称"会议通知"),会议通知载明了本次 股东大会的召开时间和地 ...
宠物医药:突破从0到1,何以从1至
2025-06-30 01:02
Summary of the Conference Call on the Pet Pharmaceutical Industry Industry Overview - The pet pharmaceutical market in China is experiencing rapid growth, with a compound annual growth rate (CAGR) of 22%, driven by rigid demand throughout the pet lifecycle [1][2] - The aging pet population is increasing, with the proportion of senior dogs over seven years old rising significantly, leading to higher demand for medications for age-related diseases [1][2] Key Insights - The market size is projected to grow from less than 9.4 billion yuan in 2020 to nearly 21 billion yuan by 2024, indicating a robust growth trajectory [2] - The demand for pet medications is characterized by its rigidity, affecting various age groups, with high incidence rates of conditions like dental calculus and skin diseases [2] - The industry faces supply bottlenecks, particularly in medications for elderly diseases, which are heavily reliant on imports [4] Supply Chain and Innovation - The industry is exploring human drug conversion to alleviate supply-demand conflicts, exemplified by the release of a directory of urgently needed human medications for pets [4] - There is a push for accelerated research and innovation to develop effective treatments for chronic diseases and tumors, with the first domestic monoclonal antibody drug clinical approval achieved in June [4] Progress in Domestic Vaccine Development - Domestic companies have made significant strides in the core vaccine sector, particularly with the launch of the first approved domestic cat trivalent vaccine by Ruipuhua in January 2024 [5][6] - By June 2025, a total of 11 domestic cat trivalent vaccines are expected to be on the market, breaking the monopoly previously held by foreign companies [5][6] Market Dynamics - The pet vaccine market is vast, with the mandatory rabies vaccine market valued at approximately 3-4 billion yuan, and both cat and dog trivalent vaccines around 2 billion yuan each [6] - Domestic vaccines have advantages in strain matching and pricing, typically being 20% cheaper than imported alternatives [7] Competitive Landscape - The cat trivalent vaccine market remains in a blue ocean state, with less than 10% immunization penetration among urban pet cats, indicating significant growth potential [8][9] - Over 10 domestic companies are involved in the pet vaccine sector, including traditional veterinary medicine firms and those transitioning from human pharmaceuticals [10] Challenges and Future Trends - Domestic companies face challenges in channel development, needing to overcome the premium pricing power of foreign brands [11] - Companies like Ruipuhua and PlaiKe are working to narrow the gap by building their own or partnering with pet hospitals [11][12] - Future trends include a focus on mRNA technology and innovative drug delivery methods, which could reshape the competitive landscape and create larger market opportunities due to the increasing management needs of aging pets [13]
瑞普生物(300119) - 关于控股子公司及其下属子公司开展资产池业务并提供担保的公告
2025-06-25 09:32
证券代码:300119 证券简称:瑞普生物 公告编号:2025-049 瑞普生物股份有限公司 关于控股子公司及其下属子公司开展资产池业务 一、担保情况概述 根据业务发展需要,瑞普生物股份有限公司(以下简称"公司")的控股子 公司天津中瑞供应链管理有限公司(以下简称"中瑞供应链")及其下属公司(包 括控股子公司及其分公司,以下简称"成员单位"),即:浙江云爱动物保健有 限公司(以下简称"浙江云爱")、浙江云爱动物保健有限公司杭州分公司(以 下简称"浙江云爱杭州分公司")、南京华和益宠生物科技有限公司(以下简称 "南京华和")、龙腾旺业生物科技(天津)有限公司(以下简称"天津龙腾")、 深圳喜越动保供应链有限公司(以下简称"深圳喜越")、重庆富德仕动物药品 有限公司(以下简称"重庆富德仕")、武汉有宠生物科技有限公司(以下简称 "武汉有宠")、上海澳物生物科技有限公司(以下简称"上海澳物")、长春 市新鑫旺供应链有限公司(以下简称"长春市新鑫旺")、杭州斑马兵兵科技有 限公司(以下简称"杭州斑马")、广西安和天成生物科技有限公司(以下简称 "广西安和")拟与浙商银行股份有限公司天津分行(以下简称"协议银行") 开 ...
光大证券农林牧渔行业周报:“618”战报出炉 宠物消费同比高增
Xin Lang Cai Jing· 2025-06-22 08:30
Group 1: Pet Economy - The pet economy continues to show high growth, with over 400 pet brands achieving sales growth of over 100% year-on-year during the "618" shopping festival [1] - The number of pet transaction users increased by 32% year-on-year, while new pet owners grew by 39% [1] - Top brands in various pet food categories include Royal Canin and Maffidi for cat and dog dry food, and Maffidi and Zeal for cat and dog snacks/wet food [1] Group 2: Pig Prices - The average price of external three yuan pigs rose to 14.22 yuan/kg, a week-on-week increase of 1.43% [2] - The average price of piglets decreased to 31.85 yuan/kg, down 3.16% week-on-week [2] - The average weight of market pigs decreased slightly to 128.28 kg, while the inventory rate of frozen products increased to 14.04% [2] Group 3: Grain Prices - Prices for corn, soybean meal, and wheat have increased, with corn averaging 2417.06 yuan/ton (up 0.47%), soybean meal at 3015.14 yuan/ton (up 1.59%), and wheat at 2441.67 yuan/ton (up 0.46%) [3] - Weather conditions and trade dynamics are influencing corn prices, while soybean meal prices are affected by supply concerns from the U.S. and geopolitical tensions [3] Group 4: Investment Recommendations - The pig farming sector is expected to enter a long-term profit growth phase after inventory reduction, with recommended companies including Juxing Agriculture, Shennong Group, and Muyuan Foods [4] - The post-cycle sector is seeing a recovery in feed and veterinary demand, with companies like Haida Group and Ruipu Biotech recommended [4] - The planting chain is showing positive fundamentals with rising grain prices, suggesting investment opportunities in companies like Suqian Agricultural Development and Beidahuang [4] - The pet food industry is in a growth phase, with increasing recognition of domestic brands and recommended companies including Guibao Pet and Zhongchong Co. [4]